Most Admired CEO honoree: Lisa Hausmann, Mercy Hospital of Folsom
"When you're authentic, and you lead with some of that vulnerability, people tend to trust you," she said. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - March 15, 2024 Category: Biotechnology Authors: Sonya Herrera Source Type: news

CRISPR Gene Drives and the Future of Evolution
Genetic engineering pioneer Kevin Esvelt’s work highlights biotechnology’s immense potential for good—but also for catastrophe. (Source: The Scientist)
Source: The Scientist - March 15, 2024 Category: Science Tags: Profile Magazine Issue Source Type: news

Why women keep choosing Holy Cross Health for maternity and perinatal care in the D.C. metro region
Madeline Rose visited Holy Cross Hospital ’s Neonatal Intensive Care Unit in her cap and gown after graduating from high school in 2019. She wanted to personally thank the NICU team for the care she received nearly 18 years earlier when she was born prematurely and weighed just 2.5 pounds. “She came with her family directly from her h igh school graduation to let our team in the NICU know that if it weren’t for them, she wouldn’t have walked across the stage that day,” said Nancy Nagel,… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - March 15, 2024 Category: Biotechnology Authors: Laura Newpoff Source Type: news

WuXi AppTec Says It Left Washington Lobbying Group Voluntarily
WuXi AppTec says it voluntarily left a high-profile biotechnology lobbying group as U.S. legislative efforts were “maligning” its membership in the Washington-based association.#wuxiapptec (Source: Reuters: Health)
Source: Reuters: Health - March 15, 2024 Category: Consumer Health News Source Type: news

How a daughter of refugees founded a biotech to combat diseases that have afflicted her family
Juvena Therapeutics CEO Hanadie Yousef has a compelling family narrative. It may have inspired her fight against chronic illnesses. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 14, 2024 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news

These are the next generation of biotech superstars in the Bay Area
We take a look at women in life sciences in the Bay Area who leading the next generation. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - March 14, 2024 Category: Pharmaceuticals Authors: William Hicks Source Type: news

National nonprofit shares insights for companies, consumers in light of recent cyberattack
Lisa Plaggemier, executive director of the National Cybersecurity Alliance, shares about the lessons learned for health care companies and government, as well as patients, in light of the Change Healthcare cyberattack. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - March 14, 2024 Category: Biotechnology Authors: Kelsey Kukaua Medeiros Source Type: news

Sutter Health partners with historically Black medical school in Los Angeles to launch diverse pipeline of doctors
Sutter Health has launched a new partnership aimed at training more doctors from diverse backgrounds and addressing health inequities. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - March 14, 2024 Category: Biotechnology Authors: Emily Hamann Source Type: news

Cancer drug from Peninsula company wins FDA advisory committee thumbs up
The decision moves Geron closer to its first drug approval in its three decades. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - March 14, 2024 Category: Biotechnology Authors: Ron Leuty Source Type: news

Shares of Madrigal Pharmaceuticals soar on FDA approval for NASH treatment
Conshohocken-based Madrigal Pharmaceutical has emerged as the winner in the race to be the first drug company to secure approval for a treatment targeting a liver disease known as NASH. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - March 14, 2024 Category: Biotechnology Authors: John George Source Type: news

Oregon allows health care giant's acquisition of a medical practice to move forward
Public sentiment about Optum's proposed acquisition of The Corvallis Clinic was largely negative, but the clinic argued it was in dire financial straits. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - March 14, 2024 Category: Biotechnology Authors: Elizabeth Hayes Source Type: news

UT Health San Antonio President Henrich has died
Those who worked with the longtime leader say he was a visionary who transformed the Alamo City institute. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - March 14, 2024 Category: Biotechnology Authors: W. Scott Bailey Source Type: news

Knight Cancer Institute's Brian Druker on why he's 'stepping up, not out' with new role
Druker is handing day-to-day operations to a new director but will continue as CEO to focus on the big picture. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - March 14, 2024 Category: Biotechnology Authors: Elizabeth Hayes Source Type: news

'It's keeping health care local:' Washington Health System CEO Brook Ward outlines the need for an affiliation with UPMC
Economic headwinds have ultimately pushed WHS, like so many other small health systems before it, to seek to become part of a larger system. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - March 14, 2024 Category: Biotechnology Authors: Jordyn Hronec Source Type: news

Prices of 800 essential drugs to increase a tad from April 1
After massive annual increases of 12% and 10% in prices on record last year and in 2022, this will be a meagre increase for the pharma industry. The adjusted prices will cover more than 800 drugs on the National List of Essential Medicines. Price changes for scheduled drugs are allowed once a year. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - March 14, 2024 Category: Pharmaceuticals Source Type: news